Category: Clinical Breakthroughs
-
Northwestern Helps Develop Custom Drug
A one-of-a-kind drug created to treat a single patient passed a crucial test at Northwestern, according to a study published in the New England Journal of Medicine.
-
Combination Treatment Beats Chemotherapy in Breast Cancer
A new review has found that a combination of endocrine inhibitors and hormone therapy is more effective in prolonging progression-free survival for advanced breast cancer patients, as compared to chemotherapy.
-
New Molecule Blocks ‘Undruggable’ Cancer Protein
Northwestern Medicine scientists have created a small molecule that reduces expression of MYC, a cancer-causing protein involved in a wide variety of cancers.
-
Pacemakers Could Help Avoid Future Strokes
Measuring atrial fibrillation through implanted devices like pacemakers can identify patients at risk for stroke, according to a recent study.
-
Women Surgical Residents Suffer More Mistreatment, Leading to Burnout and Suicidal Thoughts
Women surgical residents suffer more mistreatment than men, which leads to a higher burnout rate and more suicidal thoughts among female residents, according to a new Northwestern Medicine study.
-
Improving the Physician Referral Process with Peer Evaluations
Gregory Brisson, MD, discussed how peer evaluation among physicians could enhance the patient referral process in a recent NEJM editorial.
-
Improving Predictions of Kidney Transplant Success
A recent study found that the genetic distance between kidney donors and recipients could be used to more accurately predict transplant success.
-
Diabetes Drug May Help Treat Heart Failure Too
A drug originally designed to help manage diabetes may also improve quality of life for patients with heart failure, according to a recent clinical trial.
-
Study Assesses Asthma Treatment Options in African American Children and Adults
The use of long-acting bronchodilators to treat asthma had no impact for some African-American children, according to a new study from Ann & Robert H. Lurie Children’s Hospital of Chicago and the Department of Pediatrics.
-
New Heart Failure Drug Fails to Reduce Hospitalizations
A new Northwestern Medicine study found an experimental drug did not lower hospitalization among patients suffering from heart failure with preserved ejection fraction.
